COMMUNIQUÉS West-GlobeNewswire

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
06/01/2026
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer IRVINE, CA – January XX, 2026 ( GlobeNewswire ) – Mdxhealth SA ( [...]
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter
06/01/2026
ST. LOUIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained U.S. Food and Drug [...]
24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business
06/01/2026
How Decades of Innovation Are Converging for Commercial Spider Silk Success DENVER, Jan. 06, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial [...]
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
06/01/2026
Distinguished drug-development and biomarker leader to advance NAMkind™ scientific strategy, translational insights, and next-generation toxicology platforms SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, [...]
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer
06/01/2026
Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readiness Company on track to initiate first-in-human (FIH) trial for the treatment of ovarian cancer in the second [...]
Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
06/01/2026
~ Annual/Special Meeting of Shareholders to be Held on January 30, 2026 ~ WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP ) (“Coeptis” or the “Company”), a next-gen [...]
SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets
06/01/2026
Smaller 5-millimeter instruments to be incorporated into the SSi Mantra surgical robotic system FORT LAUDERDALE, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS [...]
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy
06/01/2026
MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
06/01/2026
CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present [...]
Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry
06/01/2026
Pilot launched with six registered dental professionals; program expected to scale to 250 ambassadors over 12 months ROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading [...]
LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.
06/01/2026
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced the closing of a new senior secured revolving credit facility (“ [...]
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
06/01/2026
HOUSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the [...]
Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development
06/01/2026
ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, [...]
Prestigious Research University Integrates SteraMist Hybrid System for Advanced Medical Product Sterilization
06/01/2026
FREDERICK, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today the purchase of its [...]
Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers
06/01/2026
Two Complete Metabolic Responses (CMRs) observed in patients with relapsed/refractory metastatic Ewing sarcoma and one Complete Response (CR) observed in a patient with relapsed/refractory metastatic neuroblastoma [...]
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference
06/01/2026
DENVER, Jan. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]
Medical AI Expert Wido Menhardt Joins FemPulse Scientific Advisory Board
06/01/2026
SAN FRANCISCO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- FemPulse TM , a bioelectronic medical technology company with first application overactive bladder, announced today that medical AI expert Wido Menhardt, PhD has joined [...]
Visory Health Named to Inc.’s Best in Business for Excellence in Social Good
06/01/2026
The health tech company is honored for delivering meaningful cost-saving solutions and strengthening community healthcare access ESTERO, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Visory Health , a patient-first health [...]
2026 New Year’s Greetings from the CEO
06/01/2026
LA JOLLA, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) [...]

Pages